Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.
Department of Epidemiology and Social Medicine, University of Antwerp, Antwerpen, Belgium.
Am J Obstet Gynecol. 2019 Jul;221(1):48.e1-48.e18. doi: 10.1016/j.ajog.2019.02.040. Epub 2019 Feb 23.
Subfertility among couples affected by HIV has an impact on the well-being of couples who desire to have children and may prolong HIV exposure. Subfertility in the antiretroviral therapy era and its determinants have not yet been well characterized.
The objective of the study was to investigate the burden and determinants of subfertility among HIV-affected couples seeking safer conception services in South Africa.
Nonpregnant women and male partners in HIV seroconcordant or HIV discordant relationships desiring a child were enrolled in the Sakh'umndeni safer conception cohort at Witkoppen Clinic in Johannesburg between July 2013 and April 2017. Clients were followed up prospectively through pregnancy (if they conceived) or until 6 months of attempted conception, after which they were referred for infertility services. Subfertility was defined as not having conceived within 6 months of attempted conception. Robust Poisson regression was used to assess the association between baseline characteristics and subfertility outcomes; inverse probability weighting was used to account for missing data from women lost to safer conception care before 6 months of attempted conception.
Among 334 couples enrolled, 65% experienced subfertility (inverse probability weighting weighted, 95% confidence interval, 0.59-0.73), of which 33% were primary subfertility and 67% secondary subfertility. Compared with HIV-negative women, HIV-positive women not on antiretroviral therapy had a 2-fold increased risk of subfertility (weighted and adjusted risk ratio, 2.00; 95% confidence interval, 1.19-3.34). Infertility risk was attenuated in women on antiretroviral therapy but remained elevated, even after ≥2 years on antiretroviral therapy (weighted and adjusted risk ratio, 1.63; 95% confidence interval, 0.98-2.69). Other factors associated with subfertility were female age (weighted and adjusted risk ratio, 1.03, 95% confidence interval, 1.01-1.05 per year), male HIV-positive status (weighted and adjusted risk ratio, 1.31; 95% confidence interval, 1.02-1.68), male smoking (weighted and adjusted risk ratio, 1.29; 95% confidence interval, 1.05-1.60), and trying to conceive for ≥1 year (weighted and adjusted risk ratio, 1.38; 95% confidence interval, 1.13-1.68).
Two in 3 HIV-affected couples experienced subfertility. HIV-positive women were at increased risk of subfertility, even when on antiretroviral therapy. Both male and female HIV status were associated with subfertility. Subfertility is an underrecognized reproductive health problem in resource-limited settings and may contribute to prolonged HIV exposure and transmission within couples. Low-cost approaches for screening and treating subfertility in this population are needed.
受 HIV 影响的夫妇的生育能力低下会影响那些希望生育孩子的夫妇的幸福感,并可能延长 HIV 的暴露时间。在抗逆转录病毒治疗时代,生育能力低下及其决定因素尚未得到很好的描述。
本研究旨在调查在南非寻求更安全受孕服务的受 HIV 影响的夫妇中生育能力低下的负担和决定因素。
2013 年 7 月至 2017 年 4 月期间,在约翰内斯堡威茨科普班恩诊所,HIV 血清学一致或 HIV 血清学不一致的希望生育孩子的未怀孕女性及其男性伴侣参加了 Sakh'umndeni 更安全受孕队列研究。通过妊娠(如果受孕)或尝试受孕 6 个月后对客户进行前瞻性随访,在尝试受孕 6 个月后,他们被转诊到不孕不育服务机构。生育能力低下定义为尝试受孕 6 个月内未受孕。使用稳健泊松回归评估基线特征与生育能力低下结果之间的关联;使用逆概率加权来解释在尝试受孕 6 个月之前因更安全受孕护理而失去的女性的缺失数据。
在 334 对夫妇中,65%的夫妇出现生育能力低下(逆概率加权,95%置信区间,0.59-0.73),其中 33%为原发性生育能力低下,67%为继发性生育能力低下。与 HIV 阴性女性相比,未接受抗逆转录病毒治疗的 HIV 阳性女性生育能力低下的风险增加了两倍(加权和调整后的风险比,2.00;95%置信区间,1.19-3.34)。接受抗逆转录病毒治疗的女性的不孕风险有所降低,但即使在接受抗逆转录病毒治疗 2 年以上后,风险仍然升高(加权和调整后的风险比,1.63;95%置信区间,0.98-2.69)。其他与生育能力低下相关的因素包括女性年龄(加权和调整后的风险比,1.03;95%置信区间,1.01-1.05 岁/年)、男性 HIV 阳性状态(加权和调整后的风险比,1.31;95%置信区间,1.02-1.68)、男性吸烟(加权和调整后的风险比,1.29;95%置信区间,1.05-1.60)和尝试受孕 1 年以上(加权和调整后的风险比,1.38;95%置信区间,1.13-1.68)。
三分之二的受 HIV 影响的夫妇出现生育能力低下。即使接受抗逆转录病毒治疗,HIV 阳性女性生育能力低下的风险也会增加。男性和女性的 HIV 状况都与生育能力低下有关。生育能力低下是资源有限环境中一个未被充分认识的生殖健康问题,可能导致夫妇中 HIV 暴露和传播时间延长。需要针对该人群制定低成本的生育能力低下筛查和治疗方法。